{ "company_number": "08556296", "name": "Newtone Pharma Limited", "url": "/company/08556296", "status": "Active", "is_active": true, "company_type": "Private Limited Company", "incorporated_on": "2013-06-05", "dissolved_on": null, "sic_codes": [ "46360", "46460", "46900" ], "registered_address": { "id": 897562, "url": "/address/897562", "line1": "SUITE 23018 8 SHEPHERD MARKET", "line2": "MAYFAIR", "post_town": "LONDON", "county": "", "country": "ENGLAND", "postcode": "W1J 7JY" }, "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/08556296", "previous_names": [], "care_of": "", "po_box": "", "country_of_origin": "United Kingdom", "accounts": { "next_due": "2027-03-31", "last_made_up": "2025-06-30", "category": "TOTAL EXEMPTION FULL", "filings": [ { "url": "/company/08556296/accounts/2025-06-30", "made_up_date": "2025-06-30", "period_start": "2024-07-01", "period_end": "2025-06-30", "entity_name": "Newtone Pharma Limited", "dormant": false, "average_employees": "0.00", "tangible_fixed_assets": "59246.00", "debtors": null, "cash_bank_in_hand": "7167.00", "current_assets": "7167.00", "creditors_due_within_one_year": "7587.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "-420.00", "total_assets_less_current_liabilities": "58826.00", "net_assets_liabilities": "-166987.00", "called_up_share_capital": "1000.00", "profit_loss_account_reserve": "-167987.00", "shareholder_funds": "1000.00", "turnover": "879268.00", "other_operating_income": null, "cost_sales": "837351.00", "gross_profit_loss": "41917.00", "administrative_expenses": "1986.00", "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": "39931.00", "profit_before_tax": "39931.00", "tax_on_profit": "7587.00", "profit_loss_for_period": "32344.00", "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-November2025.zip" }, { "url": "/company/08556296/accounts/2024-06-30", "made_up_date": "2024-06-30", "period_start": "2023-07-01", "period_end": "2024-06-30", "entity_name": "Newtone Pharma Limited", "dormant": false, "average_employees": "1.00", "tangible_fixed_assets": "59246.00", "debtors": null, "cash_bank_in_hand": "17689.00", "current_assets": "17689.00", "creditors_due_within_one_year": "8043.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "9646.00", "total_assets_less_current_liabilities": "68892.00", "net_assets_liabilities": "-206921.00", "called_up_share_capital": "1000.00", "profit_loss_account_reserve": "207921.00", "shareholder_funds": "1000.00", "turnover": "1014584.00", "other_operating_income": null, "cost_sales": "970481.00", "gross_profit_loss": "44103.00", "administrative_expenses": "1774.00", "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": "42329.00", "profit_before_tax": "42329.00", "tax_on_profit": "8043.00", "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-March2025.zip" }, { "url": "/company/08556296/accounts/2023-06-30", "made_up_date": "2023-06-30", "period_start": "2023-06-30", "period_end": "2023-06-30", "entity_name": "Newtone Pharma Limited", "dormant": false, "average_employees": "1.00", "tangible_fixed_assets": null, "debtors": null, "cash_bank_in_hand": null, "current_assets": "109605.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "109605.00", "total_assets_less_current_liabilities": "109605.00", "net_assets_liabilities": "241208.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "241208.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-February2024.zip" }, { "url": "/company/08556296/accounts/2022-06-30", "made_up_date": "2022-06-30", "period_start": "2022-06-30", "period_end": "2022-06-30", "entity_name": "Newtone Pharma Limited", "dormant": false, "average_employees": "1.00", "tangible_fixed_assets": null, "debtors": null, "cash_bank_in_hand": null, "current_assets": "119503.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "44134.00", "total_assets_less_current_liabilities": "44134.00", "net_assets_liabilities": "653924.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "653924.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-September2022.zip" }, { "url": "/company/08556296/accounts/2021-06-30", "made_up_date": "2021-06-30", "period_start": "2021-06-30", "period_end": "2021-06-30", "entity_name": "Newtone Pharma Limited", "dormant": false, "average_employees": "1.00", "tangible_fixed_assets": null, "debtors": null, "cash_bank_in_hand": "18244.00", "current_assets": "77813.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "-85824.00", "total_assets_less_current_liabilities": "-85824.00", "net_assets_liabilities": "-695614.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "1000.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-November2021.zip" }, { "url": "/company/08556296/accounts/2020-06-30", "made_up_date": "2020-06-30", "period_start": "2020-06-30", "period_end": "2020-06-30", "entity_name": "Newtone Pharma Limited", "dormant": false, "average_employees": "1.00", "tangible_fixed_assets": null, "debtors": null, "cash_bank_in_hand": "2103.00", "current_assets": "61672.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "-101215.00", "total_assets_less_current_liabilities": "-101215.00", "net_assets_liabilities": "-711005.00", "called_up_share_capital": "1000.00", "profit_loss_account_reserve": "-712005.00", "shareholder_funds": "1000.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-November2020.zip" }, { "url": "/company/08556296/accounts/2019-06-30", "made_up_date": "2019-06-30", "period_start": "2019-06-30", "period_end": "2019-06-30", "entity_name": "Newtone Pharma Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": null, "debtors": null, "cash_bank_in_hand": "29019.00", "current_assets": "88589.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "-74298.00", "total_assets_less_current_liabilities": "-74298.00", "net_assets_liabilities": "-684088.00", "called_up_share_capital": "1000.00", "profit_loss_account_reserve": "-685088.00", "shareholder_funds": "1000.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-January2020.zip" }, { "url": "/company/08556296/accounts/2018-06-30", "made_up_date": "2018-06-30", "period_start": "2018-06-30", "period_end": "2018-06-30", "entity_name": "Newtone Pharma Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": null, "debtors": null, "cash_bank_in_hand": "36623.00", "current_assets": "127285.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "-15307.00", "total_assets_less_current_liabilities": "-15307.00", "net_assets_liabilities": "-625097.00", "called_up_share_capital": "1000.00", "profit_loss_account_reserve": "-626097.00", "shareholder_funds": "1000.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-January2019.zip" }, { "url": "/company/08556296/accounts/2017-06-30", "made_up_date": "2017-06-30", "period_start": "2017-06-30", "period_end": "2017-06-30", "entity_name": "Newtone Pharma Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": null, "debtors": null, "cash_bank_in_hand": "39625.00", "current_assets": "130287.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "67291.00", "total_assets_less_current_liabilities": "67291.00", "net_assets_liabilities": "-542499.00", "called_up_share_capital": "1000.00", "profit_loss_account_reserve": "-543499.00", "shareholder_funds": "1000.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-December2017.zip" }, { "url": "/company/08556296/accounts/2016-06-30", "made_up_date": "2016-06-30", "period_start": "2016-06-30", "period_end": "2016-06-30", "entity_name": "Newtone Pharma Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": null, "debtors": null, "cash_bank_in_hand": "167376.00", "current_assets": "258037.00", "creditors_due_within_one_year": "18955.00", "creditors_due_after_one_year": "530248.00", "net_current_assets_liabilities": "239082.00", "total_assets_less_current_liabilities": "239082.00", "net_assets_liabilities": "-291166.00", "called_up_share_capital": "1000.00", "profit_loss_account_reserve": "-292166.00", "shareholder_funds": "-291166.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-November2016.zip" }, { "url": "/company/08556296/accounts/2015-06-30", "made_up_date": "2015-06-30", "period_start": "2015-06-30", "period_end": "2015-06-30", "entity_name": "Newtone Pharma Limited", "dormant": true, "average_employees": null, "tangible_fixed_assets": null, "debtors": null, "cash_bank_in_hand": "1000.00", "current_assets": null, "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": null, "total_assets_less_current_liabilities": null, "net_assets_liabilities": "1000.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "1000.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-August2015.zip" }, { "url": "/company/08556296/accounts/2014-06-30", "made_up_date": "2014-06-30", "period_start": "2014-06-30", "period_end": "2014-06-30", "entity_name": "Newtone Pharma Limited", "dormant": true, "average_employees": null, "tangible_fixed_assets": null, "debtors": null, "cash_bank_in_hand": "1000.00", "current_assets": null, "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": null, "total_assets_less_current_liabilities": null, "net_assets_liabilities": "1000.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "1000.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-June2014.zip" } ], "pdf_only_filings": [], "filing_history_url": "https://find-and-update.company-information.service.gov.uk/company/08556296/filing-history" }, "confirmation_statement": { "next_due": "2027-06-19", "last_made_up": "2026-06-05" }, "officers": [], "psc": [ { "name": "Mr Robert Simasko", "kind": "individual-person-with-significant-control", "person_url": "/person/4271518", "controlling_company_url": null, "natures_of_control": [ "ownership-of-shares-75-to-100-percent" ], "notified_on": "2018-10-03", "ceased_on": "2019-12-03", "nationality": "Estonian", "country_of_residence": "Estonia", "source": "snapshot" }, { "name": "Mr Volodymyr Dzhus", "kind": "individual-person-with-significant-control", "person_url": "/person/5188375", "controlling_company_url": null, "natures_of_control": [ "ownership-of-shares-75-to-100-percent", "voting-rights-75-to-100-percent" ], "notified_on": "2019-12-03", "ceased_on": "2020-03-02", "nationality": "Ukrainian", "country_of_residence": "Ukraine", "source": "snapshot" }, { "name": "Mr Robert Simasko", "kind": "individual-person-with-significant-control", "person_url": "/person/4271518", "controlling_company_url": null, "natures_of_control": [ "ownership-of-shares-75-to-100-percent", "voting-rights-75-to-100-percent" ], "notified_on": "2020-03-02", "ceased_on": "2020-06-24", "nationality": "Estonian", "country_of_residence": "Estonia", "source": "snapshot" }, { "name": "Mr Volodymyr Dzhus", "kind": "individual-person-with-significant-control", "person_url": "/person/5188375", "controlling_company_url": null, "natures_of_control": [ "ownership-of-shares-75-to-100-percent", "voting-rights-75-to-100-percent" ], "notified_on": "2020-06-24", "ceased_on": "2020-11-11", "nationality": "Ukrainian", "country_of_residence": "Ukraine", "source": "snapshot" }, { "name": "Mr Dmytro Gunchenko", "kind": "individual-person-with-significant-control", "person_url": "/person/1328109", "controlling_company_url": null, "natures_of_control": [ "ownership-of-shares-75-to-100-percent", "voting-rights-75-to-100-percent" ], "notified_on": "2020-11-11", "ceased_on": null, "nationality": "Ukrainian", "country_of_residence": "Ukraine", "source": "snapshot" } ], "external_links": [], "provenance": { "source": "snapshot", "first_seen_at": "2026-07-05T12:35:35.811816+00:00", "last_seen_snapshot": "2026-08-01", "retrieved_at": "2026-08-02T05:12:20.351914+00:00" }, "licence": "Open Government Licence v3.0", "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/", "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: Companies House." }